A carregar...
Publicação
Tuberculose, o que há de novo
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 966.24 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
A tuberculose éum importante problema de saúde publica,tendo uma prevalência global,e podendo mesmo incorrer na mortalidade dos infectados.Esta situação ganha ainda mais impotância com o advento da resistência ao antibioticos.Em conclisão o tratamento que ainda passa pela rifampicina e isoniazida deve ser avaliado de acordo com a susceptibilidade de micobactéria que definará a dose oueventuais combinações destes fármacosa
Tuberculosis is a major public health problem,with a global prevalence,which may cause even death of infected people.The disease also affects developed countries due to increasing human migration and subsequent transit of citizen from various parts of the world.In conclusion,the regimens still containing rifampicin and isoniasid should be avaluated according to its effectiveness against Mycobacterium and define the dose or possible combinations of these or other drugs
Tuberculosis is a major public health problem,with a global prevalence,which may cause even death of infected people.The disease also affects developed countries due to increasing human migration and subsequent transit of citizen from various parts of the world.In conclusion,the regimens still containing rifampicin and isoniasid should be avaluated according to its effectiveness against Mycobacterium and define the dose or possible combinations of these or other drugs
Descrição
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de Farmácia, 2019
Palavras-chave
Tuberculosis Infection Mycobacterium Patients Treatment Diseasw,Tb-drugs. Mestrado Integrado - 2019